
The statement put Rajji in the crosshairs of Hezbollah supporters, with several prominent figures releasing statements condemning the Foreign Minister and his statement during the interview.
Youssef Rajji, the Minister of Foreign Affairs of Lebanon, said that "so long as Hezbollah is not completely disarmed, Israel has the right to continue its attacks," in an interview with Sky News, N12 reported on Wednesday.
The statement put Rajji in the crosshairs of Hezbollah supporters, with several prominent figures releasing statements condemning the Foreign Minister and his statement during the interview.
Lebanese pro-Hezbollah newspaper Al Akhbar published a piece describing Rajji as the "speaker of the enemy in the government," and called for the Lebanese Prime Minister and President to take action against him.
"He did not hesitate to turn the Foreign Ministry into a mobile mouthpiece for distraction, using diplomatic hybrid language which addresses the other side using rhetoric and not political speech," Al Akhbar said. "There is no point in warning him, or directing his attention away, because the whole Foreign Ministry is no longer Lebanese in its rhetoric or role."
Hezbollah member of Parliament stands against Rajji
Ali Ammar, a Hezbollah member of the Lebanese Parliament, also denounced Rajji, calling him "a resonant political, national, and moral failure."
Ammar also urged the Prime Minister and President to take a stand against Rajji's words.
The Secret Destinations Amex Says Will Be More Popular Than Bali by 2026
Etymological Experiences on the Wireless transmissions: A Survey of \Learning in a hurry\ Language Web recording
The Way to Business: Startup Illustrations Learned
Step by step instructions to Shield Your Wellbeing Around 5G Pinnacles\
5 things for parents to know about changes to kids vaccine schedule
Uzbekistan launches €9.46 billion green energy push, covering nation’s power needs
Vote In favor of Your Favored Sort Of Dress
Europe pledges over €15bn for clean energy for Africa
Judge approves Purdue Pharma’s new $7B opioid settlement with the Sacklers













